Parameters | Control (n = 10) | Prostate cancer (n = 10) | Pure VC (n = 10) | VC-NFs (n = 10) | Range (Unit) |
---|---|---|---|---|---|
RBC profile | |||||
 RBC count | 5.93 ± 0.27 | 3.41 ± 0.23 | 3.09 ± 0.29 | 5.11 ± 0.31 | 4–5.9 × 1012/l |
 Haemoglobin | 14.53 ± 0.25 | 9.22 ± 0.21 | 7.36 ± 0.29 | 10.7 ± 0.27 | 12–16 × g/dl |
 Haematocrit | 46.67 ± 1.17 | 31.56 ± 1.15 | 31.34 ± 1.09 | 32.07 ± 1.19 | 35–50% |
 MCV | 45.14 ± 0.59 | 100.12 ± 0.61 | 89.53 ± 0.59 | 71.34 ± 0.57 | 40–60 fl |
 MCH | 24.67 ± 0.58 | 17.29 ± 0.59 | 16.48 ± 0.55 | 19.58 ± 0.56 | 21–31 pg |
 MCHC | 31.33 ± 0.59 | 49.35 ± 0.55 | 46.24 ± 0.55 | 41.47 ± 0.56 | 30–39% |
 Haemolysis | 2 ± 0 | 12.33 ± 0.4 | 25.83 ± 0.5 | 15.32 ± 0.3 | 0% |
 RBC morphology | Normal | Macrocytic | Spheroidal | Spheroidal | Normal |
WBC Profile | |||||
 WBC count | 7.37 ± 1.27 | 31.22 ± 1.25 | 1.01 ± 1.22 | 4.37 ± 1.17 | 4.5–11.0 × 103/µl |
 Neutrophils | 4.21 ± 2.65 | 89.21 ± 2.48 | 11.88 ± 1.29 | 24.78 ± 2.69 | 21–57% |
 Lymphocytes | 6.67 ± 3.06 | 92.67 ± 3.09 | 32.22 ± 2.89 | 45.48 ± 2.91 | 49–82% |
 Monocytes | 1.67 ± 0.59 | 9.38 ± 0.55 | 0.99 ± 0.58 | 1.02 ± 0.51 | 1.7–4.3% |
 Eosinophils | 2.33 ± 0.29 | 17.27 ± 0.27 | 10.22 ± 0.26 | 7.46 ± 0.26 | 0–3% |
 Basophils | 2.33 ± 0.27 | 0.25 ± 0.26 | 0.57 ± 0.27 | 1.64 ± 0.27 | 0–3% |
 WBC morphology | Normal | Normal | Abnormal | Abnormal | Normal |
Platelet profile | |||||
 Count | 375,000 ± 0.39 | 480,000 ± 0.47 | 329,000 ± 0.43 | 367,000 ± 0.36 | 150,000–450,000 μl |
 Morphology | Normal | Normal | Normal | Normal | Normal |
Kidney function test | |||||
BUN | 15.39 ± 0.19 | 28.29 ± 0.39 | 24.66 ± 1.02 | 18.45 ± 0.31 | 18–29 mg/dl |
Creatinine | 0.1 ± 0.01 | 0.37 ± 0.21 | 0.49 ± 0.20 | 0.38 ± 0.19 | 0.1–0.4 mg/dl |
Liver function test | |||||
 ALT | 14.32 ± 3.38 | 59.19 ± 3.68 | 48.39 ± 4.37 | 31.23 ± 4.85 | 4.1–36 U/L |
 AST | 10.93 ± 2.27 | 35.25 ± 3.41 | 49.68 ± 2.44 | 25.66 ± 4.91 | 8.1–33 U/L |
 ALP | 17.21 ± 2.46 | 48.26 ± 3.49 | 68.97 ± 2.57 | 36.33 ± 5.26 | 4.1–40 U/L |